Currently out of the existing stock ratings of Gena Wang, 228 are a BUY (67.86%), 73 are a HOLD (21.73%), 35 are a SELL (10.42%).

Gena Wang

Work Performance Price Targets & Ratings Chart

Analyst Gena Wang, currently employed at BARCLAYS, carries an average stock price target met ratio of 62.17% that have a potential upside of 30.99% achieved within 172 days.

Gena Wang’s has documented 655 price targets and ratings displayed on 48 stocks. The coverage is on Healthcare, Energy, Technology sectors.

Most recent stock forecast was given on CLLS, Cellectis SA at 16-Oct-2025.

Wall Street Analyst Gena Wang

Analyst best performing recommendations are on SMCI (SUPER MICRO COMPUTER).
The best stock recommendation documented was for SMCI (SUPER MICRO COMPUTER) at 2/13/2024. The price target of $961 was fulfilled within 2 days with a profit of $169.51 (21.42%) receiving and performance score of 107.08.

Average potential price target upside

of $123.75 (81.83%) on ABEO (ABEONA THERAPEUTICS).
of $112.62 (29.88%) on SMCI (SUPER MICRO COMPUTER).
of $40.28 (13.46%) on VRTX (VERTEX PHARMACEUTICALS).

ALNY Alnylam Pharmaceuticals ARCT Arcturus Therapeutics Holdings AVRO AVROBIO BCRX BioCryst Pharmaceuticals BEAM Beam Therapeutics BLUE Bluebird bio CLVS Clovis Oncology CRSP Crispr Therapeutics AG DBTX Decibel Therapeutics EDIT Editas Medicine IONS Ionis Pharmaceuticals KOD Kodiak Sciences LOGC LogicBio Therapeutics NTLA Intellia Therapeutics PBYI Puma Biotechnology PGNX Progenics Pharmaceuticals PTCT PTC Therapeutics RARE Ultragenyx RGNX Regenxbio SGEN Seagen SGMO Sangamo Therapeutics SGTX Sigilon Therapeutics SLDB Solid Biosciences LLC SRPT Sarepta Therapeutics VIR Vir Biotechnology BMRN Biomarin Pharmaceutical ONCE Spark Therapeutics VRTX Vertex Pharmaceuticals CLLS Cellectis SA MGTX MeiraGTx Holdings PLC MRNA Moderna ORTX Orchard Therapeutics PLC ZYME Zymeworks Common Stock IDRA Idera Pharmaceuticals LEGN Legend Biotech Corp ABEO Abeona Therapeutics DTIL Precision BioSciences HALO Halozyme Therapeutics MRTX Mirati Ther RTRX Travere Therapeutics SUN Sunoco LP JBL Jabil Circuit SMCI Super Micro Computer CYTK Cytokinetics EIDX Eidos Therapeutics FDMT 4D Molecular Therapeutics RNA Avidity Biosciences RXDX Prometheus Biosciences

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Jessica Fye (JPMORGAN)